Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03332667
Title MIBG With Dinutuximab +/- Vorinostat
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors New Approaches to Neuroblastoma Therapy Consortium
Indications

ganglioneuroblastoma

neuroblastoma

Therapies

131I-MIBG + Dinutuximab + Sargramostim + Vorinostat

131I-MIBG + Dinutuximab + Sargramostim

Age Groups: adult | child
Covered Countries USA


No variant requirements are available.